Cargando…

The hepatoprotective role of reduced glutathione and its underlying mechanism in oxaliplatin-induced acute liver injury

Currently, the underlying mechanism of oxaliplatin (OXA) induced live injury is unclear. In addition, there is no standard clinical treatment for OXA-induced acute liver injury (ALI). In this study, we established an animal model of OXA-induced ALI, and studied the role of oxidative stress in OXA-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Youzhi, Li, Yongqiang, Hu, Xiaohua, Liu, Zhihui, Chen, Jun, Lu, Yulei, Liu, Juan, Liao, Sina, Zhang, Yumei, Liang, Rong, Lin, Yan, Li, Qian, Liang, Caoyong, Yuan, Chunling, Liao, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780741/ https://www.ncbi.nlm.nih.gov/pubmed/29403564 http://dx.doi.org/10.3892/ol.2017.7594

Ejemplares similares

Holliday Cross-Recognition Protein HJURP: Association With the Tumor Microenvironment in Hepatocellular Carcinoma and With Patient Prognosis
por: Luo, Dongcheng, et al.
Publicado: (2022)

Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for Over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1)
por: Luo, Dongcheng, et al.
Publicado: (2022)

Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
por: Liang, Rong, et al.
Publicado: (2021)

Curcumin Attenuates Oxaliplatin-Induced Liver Injury and Oxidative Stress by Activating the Nrf2 Pathway
por: Lu, Yulei, et al.
Publicado: (2020)

Clinical efficacy and safety of apatinib in patients with advanced colorectal cancer as the late-line treatment
por: Liao, Xiaoli, et al.
Publicado: (2018)

(18)F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma
por: Liao, Xiaoli, et al.
Publicado: (2018)

Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non-alcoholic fatty liver disease mouse model
por: Lu, Yulei, et al.
Publicado: (2019)

Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma
por: Xie, Mingzhi, et al.
Publicado: (2018)

Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin-induced model of liver injury
por: Zou, Xueqing, et al.
Publicado: (2018)

Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy
por: Lin, Yan, et al.
Publicado: (2022)

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
por: Liu, Ziyu, et al.
Publicado: (2019)

Effective Treatment of Low-Grade Myofibroblastic Sarcoma with Apatinib: A Case Report and Literature Review
por: Lin, Yan, et al.
Publicado: (2022)

Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis
por: Zhang, Jinyan, et al.
Publicado: (2018)

Preparation of glutathione loaded nanoemulsions and testing of hepatoprotective activity on THLE-2 cells
por: YEŞİLTEPE, Ozan, et al.
Publicado: (2021)

Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR‐138‐5p and activation of AKT/mTOR signaling pathway
por: Huang, Guolin, et al.
Publicado: (2021)

Quercetin-Induced Glutathione Depletion Sensitizes Colorectal Cancer Cells to Oxaliplatin
por: Lee, Jinkyung, et al.
Publicado: (2023)

ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance
por: Lin, Li, et al.
Publicado: (2019)

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
por: Fronik, Philipp, et al.
Publicado: (2022)

Efficiently Capturing Mitochondria-Targeted Constituents with Hepatoprotective Activity from Medicinal Herbs
por: Yang, Xing-Xin, et al.
Publicado: (2019)

Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining
por: Lin, Yan, et al.
Publicado: (2019)

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
por: Zhou, Qing-nan, et al.
Publicado: (2023)

Physicochemical Properties and In Vivo Hepatoprotective Effect of Polysaccharides from Grape Pomace
por: Miao, Wenjun, et al.
Publicado: (2023)

Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020)

Systematic Analysis of Gene Expression Alteration and Co-Expression Network of Eukaryotic Initiation Factor 4A-3 in Cancer
por: Lin, Yan, et al.
Publicado: (2018)

Serum levels of reduced glutathione, oxidized glutathione, and glutathione reductase activity in minor recurrent aphthous stomatitis patients
por: Zhang, Zichuan, et al.
Publicado: (2023)

The Effect of an Aqueous Extract of Teucrium polium on Glutathione Homeostasis In Vitro: A Possible Mechanism of Its Hepatoprotectant Action
por: Shtukmaster, Stella, et al.
Publicado: (2010)

Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis
por: Chen, Xiao-Feng, et al.
Publicado: (2022)

Effects of reduced glutathione therapy on chronic hepatitis B
por: Qian, Li, et al.
Publicado: (2017)

The In Vivo Antioxidant and Hepatoprotective Actions of Selected Chinese Teas
por: Cao, Shi-Yu, et al.
Publicado: (2020)

Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination
por: Rao, Zhiping, et al.
Publicado: (2023)

β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1
por: Li, Xiaoqiang, et al.
Publicado: (2016)

KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
por: Lin, Yu-Lin, et al.
Publicado: (2012)

Mechanism of Reduced Glutathione Induced Lysozyme Defolding and Molecular Self-Assembly
por: Guo, Dashan, et al.
Publicado: (2023)

Research progress on GP73 in malignant tumors
por: Liang, Rong, et al.
Publicado: (2018)

Hepatoprotective Activity of Vitamin E and Metallothionein in Cadmium-Induced Liver Injury in Ctenopharyngodon idellus
por: Duan, Yajiao, et al.
Publicado: (2018)

Glutathione Synthesis Regulated by CtrA Protects Ehrlichia chaffeensis From Host Cell Oxidative Stress
por: Yan, Jiaqi, et al.
Publicado: (2022)

Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines
por: Yang, Chao, et al.
Publicado: (2016)

Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer
por: Zhao, Qing, et al.
Publicado: (2015)

Polymorphism in miR-146a associated with clinical characteristics and outcomes in gastric cancer patients treated with adjuvant oxaliplatin and fluoropyrimidines
por: Liao, Yu-Qian, et al.
Publicado: (2015)

CtrA activates the expression of glutathione S-transferase conferring oxidative stress resistance to Ehrlichia chaffeensis
por: Liang, Qi’an, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4i735j0a1v15qdm7ifdvkq83ei